Epidemiology, clinical features, and prognosis of elderly adults with severe forms of influenza A (H1N1)

Journal of the American Geriatrics Society

Volumn 61, Issue 3, 2013, Pages 350-356

  Garnacho Montero, José ^a   Gutiérrez Pizarraya, Antonio ^b   Márquez, Juan A ^a   Zaragoza, Rafael ^c   Granada, Rosa ^d   Ruiz Santana, Sergio ^e   Rello, Jordi ^f   Rodríguez, Alejandro ^g  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

^c HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^e HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^f HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^g HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

Author keywords

elderly; influenza A (H1N1); mortality; oseltamivir

Indexed keywords

CORTICOSTEROID; OSELTAMIVIR;

AGED; ARTICLE; CHRONIC DISEASE; CLINICAL FEATURE; COMPARATIVE STUDY; DISEASE SEVERITY; EPIDEMIOLOGICAL DATA; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; NONHUMAN; PREDICTIVE VALUE; PREVALENCE; PROGNOSIS; VIRUS PNEUMONIA;

EID: 84875229282     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.12152     Document Type: Article

References (44)

1. Moran JL, Bristow P, Solomon PJ, et al. Mortality and length-of-stay outcomes, 1993-2003, in the binational Australian and New Zealand intensive care adult patient database. Crit Care Med 2008; 36: 46-61.
2. Colpan A, Akinci E, Erbay A, et al. Evaluation of risk factors for mortality in intensive care units: A prospective study from a referral hospital in Turkey. Am J Infect Control 2005; 33: 42-47.
3. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009; 361: 680-689.
4. Domínguez-Cherit G, Lapinsky SE, Macias AE, et al. Critically Ill patients with 2009 influenza A (H1N1) in Mexico. JAMA 2009; 302: 1880-1887.
5. Miller M, Viboud C, Simonsen L, et al. Mortality and morbidity burden associated with A/H1N1pdm influenza virus: Who is likely to be infected, experience clinical symptoms, or die from the H1N1pdm 2009 pandemic virus? PLoS Curr 2009; 1: RRN1013.
6. Kumar A, Zarychanski R, Pinto R, et al. Critically ill patients with 2009 influenza A (H1N1) infection in Canada. JAMA 2009; 302: 1872-1879.
7. Martin-Loeches I, Díaz E, Vidaur L, et al. Pandemic and post-pandemic influenza A (H1N1) infection in critically ill patients. Crit Care (London) 2011; 15: R286.
8. Díaz E, Rodríguez A, Martin-Loeches I, et al. Impact of obesity in patients infected with 2009 influenza A (H1N1). Chest 2011; 139: 382-386.
9. Maraví-Poma E, Martin-Loeches I, Regidor E, et al. Severe 2009 A/H1N1v influenza in pregnant women in Spain. Crit Care Med 2011; 39: 945-951.
10. Rello J, Rodriguez R, Jubert P, et al. Severe community-acquired pneumonia in the elderly: Epidemiology and prognosis. Study Group for Severe Community-Acquired Pneumonia. Clin Infect Dis 1996; 23: 723-728.
11. Kaplan V, Angus DC, Griffin MF, et al. Hospitalized community-acquired pneumonia in the elderly: Age- and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med 2002; 165: 766-772.
12. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: A severity of disease classification system. Crit Care Med 1985; 13: 818-829.
13. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22: 707-710.
14. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11: R31.
15. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36: 296-327.
16. Rello J, Rodríguez A, Ibañez P, et al. Intensive care adult patients with severe respiratory failure caused by influenza A (H1N1)v in Spain. Crit Care 2009; 13: R148.
17. Nguyen-Van-Tam JS, Openshaw PJM, Hashim A, et al. Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009). Thorax 2010; 65: 645-651.
18. Karageorgopoulos DE, Vouloumanou EK, Korbila IP, et al. Age distribution of cases of 2009 (H1N1) pandemic influenza in comparison with seasonal influenza. PLoS ONE 2011; 6: e21690.
19. Roriz-Cruz M, Rosset I, Montero-Odasso M,. Lower mortality from H1N1 influenza in older Argentineans: Men more affected. J Am Geriatr Soc 2010; 58: 1813-1815.
20. Lemaitre M, Carrat F,. Comparative age distribution of influenza morbidity and mortality during seasonal influenza epidemics and the 2009 H1N1 pandemic. BMC Infect Dis 2010; 10: 162.
21. Paño-Pardo JR, Viasus D, Pachõn J, et al. Pandemic 2009 A (H1N1) infection requiring hospitalization of elderly Spanish adults. J Am Geriatr Soc 2012; 60: 740-744.
22. Viasus D, Cordero E, Rodríguez-Baño J, et al. Changes in epidemiology, clinical features and severity of influenza A (H1N1) 2009 pneumonia in the first post-pandemic influenza season. Clin Microbiol Infect 2012; 18: E55-E62.
23. Fabbiani M, Sali M, Di Cristo V, et al. Prospective evaluation of epidemiological, clinical, and microbiological features of pandemic influenza A (H1N1) virus infection in Italy. J Med Virol 2011; 83: 2057-2065.
24. Van Kerkhove MD, Vandemaele KAH, Shinde V, et al. Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: A global pooled analysis. PLoS Med 2011; 8: e1001053.
25. Presanis AM, Pebody RG, Paterson BJ, et al. Changes in severity of 2009 pandemic A/H1N1 influenza in England: A Bayesian evidence synthesis. BMJ 2011; 343: d5408.
26. Skowronski DM, Hottes TS, McElhaney JE, et al. Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: Higher antibody and lower cell-mediated immune responses with advanced age. J Infect Dis 2011; 203: 158-167.
27. Thomas PG, Keating R, Hulse-Post DJ, et al. Cell-mediated protection in influenza infection. Emerging Infect Dis 2006; 12: 48-54.
28. Martín-Loeches I, Sanchez-Corral A, Diaz E, et al. Community-acquired respiratory coinfection in critically ill patients with pandemic 2009 influenza A (H1N1) virus. Chest 2011; 139: 555-562.
29. Aviram G, Bar-Shai A, Sosna J, et al. H1N1 influenza: Initial chest radiographic findings in helping predict patient outcome. Radiology 2010; 255: 252-259.
30. Louie JK, Acosta M, Winter K, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A (H1N1) infection in California. JAMA 2009; 302: 1896-1902.
31. Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009; 361: 1935-1944.
32. Randolph AG, Vaughn F, Sullivan R, et al. Critically ill children during the 2009-2010 influenza pandemic in the United States. Pediatrics 2011; 128: e1450-e1458.
33. Rodríguez A, Díaz E, Martín-Loeches I, et al. Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A. J Antimicrob Chemother 2011; 66: 1140-1149.
34. Hiba V, Chowers M, Levi-Vinograd I, et al. Benefit of early treatment with oseltamivir in hospitalized patients with documented 2009 influenza A (H1N1): Retrospective cohort study. J Antimicrob Chemother 2011; 66: 1150-1155.
35. Yang S, Cao B, Liang L, et al. Antiviral therapy and outcomes of patients with pneumonia caused by influenza A pandemic (H1N1) virus. PLoS ONE 2012; 7: e29652.
36. Ling LM, Chow AL, Lye DC, et al. Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection. Clin Infect Dis 2010; 50: 963-969.
37. Lee N, Chan PKS, Hui DSC, et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis 2009; 200: 492-500.
38. Cao B, Li X-W, Mao Y, et al. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med 2009; 361: 2507-2517.
39. Diaz E, Martin-Loeches I, Canadell L, et al. Corticosteroids therapy in patients with primary viral pneumonia due to pandemic (H1N1) 2009 influenza. J Infect 2012; 64: 311-318.
40. Kim S-H, Hong S-B, Yun S-C, et al. Corticosteroids treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: Analytic strategy using propensity scores. Am J Respir Crit Care Med 2011; 183: 1207-1214.
41. Brun-Buisson C, Richard J-CM, Mercat A, et al. Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome. Am J Respir Crit Care Med 2011; 183: 1200-1206.
42. Martin-Loeches I, Lisboa T, Rhodes A, et al. Use of early corticosteroids therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection. Intensive Care Med 2011; 37: 272-283.
43. Xi X, Xu Y, Jiang L, et al. Hospitalized adult patients with 2009 influenza A (H1N1) in Beijing, China: Risk factors for hospital mortality. BMC Infect Dis 2010; 10: 256.
44. Wunsch H, Guerra C, Barnato AE, et al. Three-year outcomes for Medicare beneficiaries who survive intensive care. JAMA 2010; 303: 849-856.